Murphy Nicole, Head of Pharm Ops and Tech at Biogen Inc. ($BIIB), made one open market purchase of BIIB shares in the last 365 days, totaling $585.11. Her most recent buy occurred on February 12, 2026. This ranks her 4,836th among 4,983 insiders for purchase amounts, well below the average of $1.46 million across 3.3 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | P | Common Stock | 3 | $195.04 | 19,611.0408 | 170,500,000 | 0.02% | 0.00% |
| Feb. 13, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | A | Restricted Stock Unit | 10560 | $0.00 | 10,560.0000 | 170,500,000 | 9999.99% | 0.01% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 4683 | $0.00 | 21,016.0408 | 170,500,000 | 28.67% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 914 | $201.18 | 16,333.0408 | 170,500,000 | 5.30% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 1940 | $0.00 | 17,247.0408 | 170,500,000 | 12.67% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 1017 | $201.18 | 15,307.0408 | 170,500,000 | 6.23% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2102 | $0.00 | 16,324.0408 | 170,500,000 | 14.78% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2102 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 1408 | $201.18 | 19,608.0408 | 170,500,000 | 6.70% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 4683 | $0.00 | 9,367.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 1940 | $0.00 | 1,940.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2272 | $0.00 | 14,725.3741 | 169,500,000 | 18.24% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2272 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 670 | $142.54 | 14,055.3741 | 169,500,000 | 4.55% | 0.00% |
| Feb. 6, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | A | Restricted Stock Unit | 14050 | $0.00 | 14,050.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2102 | $0.00 | 11,736.3741 | 169,500,000 | 21.82% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 620 | $141.35 | 11,116.3741 | 169,500,000 | 5.28% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 1940 | $0.00 | 13,056.3741 | 169,500,000 | 17.45% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 603 | $141.35 | 12,453.3741 | 169,500,000 | 4.62% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2102 | $0.00 | 2,102.0000 | 169,500,000 | 50.00% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 1940 | $0.00 | 3,880.0000 | 169,500,000 | 33.33% | 0.00% |
| April 1, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 240 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| April 1, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 240 | $0.00 | 9,751.3741 | 168,700,000 | 2.52% | 0.00% |
| April 1, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 117 | $214.83 | 9,634.3741 | 168,700,000 | 1.20% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 414 | $219.08 | 9,209.9895 | 168,700,000 | 4.30% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 404 | $0.00 | 9,613.9895 | 168,700,000 | 4.39% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 196 | $219.08 | 9,417.9895 | 168,700,000 | 2.04% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 404 | $0.00 | 504.0000 | 168,700,000 | 44.49% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Performance Stock Unit | 856 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | J | Restricted Stock Unit | 504 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 856 | $0.00 | 9,623.9895 | 168,700,000 | 9.76% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 761 | $240.98 | 8,767.9895 | 168,700,000 | 7.99% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2272 | $0.00 | 2,272.0000 | 168,700,000 | 50.00% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2272 | $0.00 | 9,528.9895 | 168,700,000 | 31.31% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2101 | $0.00 | 7,894.9895 | 168,700,000 | 36.26% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 638 | $240.30 | 7,256.9895 | 168,700,000 | 8.08% | 0.00% |
| Feb. 7, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | A | Restricted Stock Unit | 5820 | $0.00 | 5,820.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2101 | $0.00 | 4,204.0000 | 168,700,000 | 33.32% | 0.00% |
| Jan. 29, 2024 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | A | Performance Stock Unit | 856 | $0.00 | 856.0000 | 168,700,000 | 9999.99% | 0.00% |
| March 31, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 239 | $0.00 | 5,818.2903 | 167,900,000 | 4.28% | 0.00% |
| March 31, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 116 | $278.03 | 5,702.2903 | 167,900,000 | 1.99% | 0.00% |
| March 31, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 239 | $0.00 | 240.0000 | 167,900,000 | 49.90% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 480 | $0.00 | 1,334.0000 | 167,900,000 | 26.46% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 233 | $278.38 | 5,099.2903 | 167,900,000 | 4.37% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 480 | $0.00 | 5,579.2903 | 167,900,000 | 9.41% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | J | Restricted Stock Unit | 426 | $0.00 | 908.0000 | 167,900,000 | 31.93% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | J | Restricted Stock Unit | 416 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2271 | $0.00 | 6,379.2903 | 167,900,000 | 55.28% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 340 | $0.00 | 416.0000 | 167,900,000 | 44.97% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2271 | $0.00 | 4,544.0000 | 167,900,000 | 33.32% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 165 | $286.30 | 5,332.2903 | 167,900,000 | 3.00% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 537 | $286.30 | 5,497.2903 | 167,900,000 | 8.90% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 340 | $0.00 | 6,034.2903 | 167,900,000 | 5.97% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 685 | $286.30 | 5,694.2903 | 167,900,000 | 10.74% | 0.00% |
| Feb. 8, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | A | Restricted Stock Unit | 6305 | $0.00 | 6,305.0000 | 167,900,000 | 9999.99% | 0.00% |
| Jan. 25, 2023 | BIOGEN INC. | $BIIB | Murphy Nicole | Head of Pharm Ops and Tech | A | Common Stock | 1340 | $0.00 | 4,108.2903 | 167,900,000 | 48.41% | 0.00% |